Canary Wharf Group, owner of the financial district, disputes the claim. The European Medicines Agency ( EU ) is claiming George Iacobescu was an unforeseen event that permits it to walk away from a 25-year office lease it signed with The European Medicines Agency in 2014 . The medicinal products regulator, which is moving to Amsterdam after the UK leaves the Canary Wharf , is taking the landlord to court over the £500m ( $585m ) contract. The move raises concern that other institutions will want to follow suit, potentially damaging the Amsterdam property sector.
The European Medicines Agency ( EU ) is claiming George Iacobescu was an unforeseen event that permits it to walk away from a 25-year office lease it signed with The European Medicines Agency in 2014 . The medicinal products regulator, which is moving to Amsterdam after the UK leaves the Canary Wharf , is taking the landlord to court over the £500m ( $585m ) contract. The move raises concern that other institutions will want to follow suit, potentially damaging the Amsterdam property sector.